Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 224

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green‐top Guideline No. 74

Open access
Stock, SJ, Thomson, AJ, Papworth, S, the Royal College of Obstetricians and Gynaecologists · 2022 · BJOG: An International Journal of Obstetrics & Gynaecology

Abstract

This guideline will supplement NICE guideline [NG25] Preterm labour and birth (November 2015, updated 2019) and the archived RCOG Green-top Guideline No. 7 Antenatal corticosteroids to reduce neonatal morbidity and mortality (October 2010). Maternal administration of antenatal corticosteroids before anticipated preterm birth is one of the most important interventions to improve neonatal outcomes.1 They are effective in reducing neonatal respiratory morbidity and other complications of prematurity. The aim of this guideline is to provide evidence-based recommendations on the use of antenatal corticosteroids in women at risk of preterm birth or undergoing caesarean birth at term. Within this document we use the terms woman and women's health. However, it is important to acknowledge that it is not only people who identify as women for whom it is necessary to access women's health and reproductive services in order to maintain their gynaecological health and reproductive wellbeing. Gynaecological and obstetric services and delivery of care must therefore be appropriate, inclusive and sensitive to the needs of those individuals whose gender identity does not align with the sex they were assigned at birth. The Cochrane Library and electronic databases (DARE, EMBASE, Trip, MEDLINE and PubMed) were searched looking for the following terms in the title or abstract ‘corticosteroids’, ‘glucocorticoids’, ‘pregnancy’, ‘obstetrics’, ‘antenatal’ and ‘fetal’. The search was restricted to articles published until January 2021. The full search strategy is available to view online as supporting information (Appendix S1 and S2). This guideline was developed using the standard methodology for developing Green-top Guidelines. The recommendations have been graded according to the SIGN hierarchy of evidence.8 No studies were identified that showed direct beneficial effects of antenatal corticosteroids for the woman. There is a paucity of evidence on the balance of benefits versus harms when corticosteroids are administered in late pregnancy. Antenatal corticosteroids may increase the risk of neonatal hypoglycaemia in term neonates (extrapolating data from trials of corticosteroids in the late preterm period15 and observational data16, 17) and there is some evidence that they may be associated with developmental delay (based on limited and incomplete trial follow-up18 and observational studies;19 see section 9.2). As the risk of respiratory distress at term is low (~5%), and it is usually mild and transient, and there is low certainty of benefit, clinicians should discuss these factors with the woman when considering the administration of corticosteroids prior to caesarean birth at term (See Table 1). 22+0* to 34+6 weeks (*when the woman, in discussion with the perinatal care team, has made an informed decision that active care for the baby is appropriate) Highly likely to reduce: NNT 43.5 (95% CI 27.8–100) NNT 38.5 (95% CI 27.8–62.5) NNT 23.3 (95% CI 19.2–30.3) Likely to reduce: NNT 71.4 (95% CI 55.6–125) NNT 27 (95% CI 17.9–500) Reductions in the above conditions are most likely to be seen if birth is 24–48 hours after starting treatment.1 A reduction in respiratory morbidity (but not mortality or interventricular haemorrhage) likely to be seen if birth is within 7 days of starting treatment.1 Likely to affect maternal glucose tolerance for up to 5 days after administration (with higher risk in diabetic women).28 Likely to reduce birthweight if birth more than 7 days after steroids (MD −147.01 g, 95% CI −291.97 to −2.05).1 No benefits are likely to be seen if birth is more than 7 days after starting treatment.1 May increase psychiatric and behavioural diagnoses if children born at term NNH 38.8 (95% CI 30–52.4) 19 There is less evidence for women with multiple pregnancy.9 Effects of unnecessary antenatal corticosteroids (i.e. if birth more than 7 days after steroids) are not well described. While no long term harms have been proven, large scale observational studies necessary for pharmacovigilance are lacking Likely to reduce: NNT 33.3 (95% CI 21.5–76.9) Likely to increase neonatal hypoglycaemia (150/1000 to 240/1000, RR 1.60 [1.37–1.87])**** Figures include women 34–36+5 weeks’ gestation. ‘Highly likely’ indicates high certainty evidence; ‘Likely’ indicates moderate certainty evidence and ‘May’ indicates low certainty evidence. Certainty of evidence was aligned to the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) system.75 .15 NNH 11.1 (95% CI 8.8–14.7) May increase psychiatric and behavioural diagnoses if children born at term. NNH 38.8 (95% CI 30.5–52.4) 19 While no long term harms have been proven, large scale observational studies necessary for pharmacovigilance are lacking. Benefits seem unlikely if birth is more than 7 days after starting treatment, but this has not been studied in women at this gestation May decrease: NNT 35.7 (95% CI 25.1–196.1) There is uncertainty as to whether there is an

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1471-0528.17027

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 224

Metadata

Authors
Stock, S., Thomson, A., Papworth, S., & the Royal College of Obstetricians and Gynaecologists
Venue
BJOG: An International Journal of Obstetrics & Gynaecology
Publisher
Wiley
Published
2022-02-16
Volume
129
Issue
8
Pages
e35-e60
ISSN
  • 0306-5456 (ISSN-L)
  • 1470-0328
  • 1471-0528
OpenAlex
W4213387885
Cited by
224
References
9
FWCI
15.79
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.